home / stock / lmnl / lmnl quote
Last: | $8.50 |
---|---|
Change Percent: | 0.24% |
Open: | $8.48 |
Close: | $8.50 |
High: | $8.5 |
Low: | $8.48 |
Volume: | 5,095 |
Last Trade Date Time: | 09/25/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$8.5 | $8.48 | $8.5 | $8.5 | $8.48 | 5,095 | 09-25-2023 |
$8.49 | $8.48 | $8.49 | $8.5 | $8.47 | 21,850 | 09-22-2023 |
$8.4801 | $8.4865 | $8.4801 | $8.4865 | $8.4801 | 689 | 09-21-2023 |
$8.47 | $8.48 | $8.47 | $8.48 | $8.47 | 22,473 | 09-20-2023 |
$8.47 | $8.47 | $8.47 | $8.48 | $8.46 | 104,258 | 09-19-2023 |
$8.47 | $8.49 | $8.47 | $8.49 | $8.47 | 9,206 | 09-18-2023 |
$8.47 | $8.43 | $8.47 | $8.5 | $8.42 | 63,663 | 09-15-2023 |
$8.4602 | $8.4452 | $8.4602 | $8.48 | $8.4433 | 3,433 | 09-14-2023 |
$8.4406 | $8.44 | $8.4406 | $8.45 | $8.44 | 1,029 | 09-13-2023 |
$8.42 | $8.41 | $8.42 | $8.45 | $8.41 | 4,685 | 09-12-2023 |
$8.41 | $8.41 | $8.41 | $8.425 | $8.41 | 2,739 | 09-11-2023 |
$8.42 | $8.4103 | $8.42 | $8.44 | $8.41 | 2,845 | 09-08-2023 |
$8.43 | $8.41 | $8.43 | $8.43 | $8.41 | 4,081 | 09-07-2023 |
$8.4178 | $8.43 | $8.4178 | $8.43 | $8.4178 | 1,457 | 09-06-2023 |
$8.43 | $8.4318 | $8.43 | $8.44 | $8.43 | 4,832 | 09-05-2023 |
$8.44 | $8.4015 | $8.44 | $8.44 | $8.4015 | 1,813 | 09-04-2023 |
$8.44 | $8.4015 | $8.44 | $8.44 | $8.4015 | 1,813 | 09-01-2023 |
$8.41 | $8.4 | $8.41 | $8.45 | $8.4 | 2,211 | 08-31-2023 |
$8.43 | $8.4428 | $8.43 | $8.4428 | $8.42 | 5,751 | 08-30-2023 |
$8.42 | $8.43 | $8.42 | $8.43 | $8.42 | 1,040 | 08-29-2023 |
News, Short Squeeze, Breakout and More Instantly...
Liminal Biosciences Inc Company Name:
LMNL Stock Symbol:
NASDAQ Market:
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Liminal BioSciences Inc. (LMNL) is expected to report for Q3 2023
LAVAL, QC and CAMBRIDGE, England, Sept. 26, 2023 /PRNewswire/ - Liminal BioSciences Inc. ("Liminal BioSciences" or the "Company") i...